We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Microchip Test Identifies Antibiotic-Resistant Bacteria

By HospiMedica staff writers
Posted on 11 Sep 2007
A microchip test quickly and inexpensively identifies dangerous drug resistant bacteria in clinical samples.

The miniaturized microarray chips were developed by studying and identifying the dangerous genes from samples of gut bacteria including the diarrhea-causing Escherichia coli and Salmonella, which causes food poisoning. More...


In a test of the new chip screening technique, the most common antibiotic resistance gene was identified in 90% of E. coli and 56% of Salmonella bacteria from a random group of animal and human clinical samples. The tests also identified unique and previously unknown combinations of virulence genes, whose significance has not yet been determined.

Physicians and veterinarians will be able to test clinical samples from their patients for the presence of the genes for antibiotic resistance in bacteria, and receive the results within 24 hours instead of having to wait for as much as a week.

"We have developed a test chip which can accurately identify 56 virulence genes in E. coli bacteria and 54 antimicrobial resistance genes covering all the known families of Gram-negative bacteria,” said Dr. Muna Anjum from the UK Veterinary Laboratories Agency in Addlestone (UK) where the new test was developed. "Our chips have already been used very successfully in a survey of microbial resistance in human clinical isolates, foods, farm animals, and also in wild animals, where we were looking at them as possible reservoirs of infection which can transmit disease back into farm animals.”

The microchip technology will allow scientists to search for and identify important genes from other pathogens and bacteria, such as genes that may be commercially important in industrial processes such as food processing, pharmaceutical development and waste handling.

The scientists presented their new test at the Society for General Microbiology's 161st meeting, which took place at the University of Edinburgh (Edinburgh, UK), on September 3-6, 2007.


Related Links:
University of Edinburgh
UK Veterinary Laboratories Agency in Addlestone

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.